University of Sydney medicine and health researchers have been awarded a combined $8.3 million under the National Health and Medical Research Council (NHMRC) Clinical Trials and Cohort Studies grant scheme.
The NHMRC Clinical Trials and Cohort Studies scheme supports high-quality clinical trials and cohort studies that address important gaps in knowledge, leading to relevant and implementable findings for the benefit of human health.
Faculty of Medicine and Health researchers Professor Pascale Guitera, Professor Paul Keall, Professor Christine Lu and Professor Kirsten Morley were all successful with their applications aimed at improving the health and wellbeing of all Australians.
“This scheme funds studies that will ultimately lead to better treatments for Australians suffering from cancer and addiction,” said Professor Julie Cairney, Interim Deputy Vice-Chancellor (Research).
“Congratulations to Pascale, Paul, Christine and Kirsten. Their success reflects the University of Sydney’s commitment to translating outstanding research into real solutions that enhance health and wellbeing services, practices and policies.
“I also want to acknowledge the participants who will be involved in these upcoming trials. Thank you for volunteering to take part in research that holds potential in helping so many others.”
Faculty of Medicine and Health grant recipients
Professor Pascale Guitera from the Sydney School of Health Sciences has been awarded $2,723,560.25 for her project "Skin cancer UNCUT: Beyond 'if in doubt, cut it out'”, a randomised controlled trial of adjunctive in vivo reflectance confocal microscopy for skin cancer diagnosis.
Professor Paul Keall from the Sydney School of Health Sciences has received $1,861,323.82 to steer a randomised controlled trial investigating ventilation imaging to improve the quality of life for patients with lung cancer.
Professor Christine Lu from Sydney Pharmacy School has secured $1,221,849 to examine the real-world risk-benefit balancing in cancer immunotherapy.
Professor Kirsten Morley from Sydney Medical School has been awarded $2,493,196.50 to develop the CAN-AUD trial, a multi-site randomised controlled trial of cannabidiol versus placebo for the management of treatment-resistant alcohol use disorder.